Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/17863| Title: | Combined BRAF and MEK inhibition in BRAF-mutant NSCLC. | Austin Authors: | Rivalland, Gareth;Mitchell, Paul L R | Affiliation: | Department of Medical Oncology, Austin Health, Olivia Newton-John Cancer Wellness & Research Centre, Heidelberg, Victoria, Australia University of Melbourne, Victoria, Australia Thoracic Alliance for Cancer Trials, Milton, QLD, Australia |
Issue Date: | Jul-2016 | Date: | 2016-06-06 | Publication information: | Lancet Oncology 2016; 17(7): 860-862 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/17863 | DOI: | 10.1016/S1470-2045(16)30203-0 | Journal: | The Lancet Oncology | PubMed URL: | 27283865 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.